Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

ClinicalTrials.gov ID: NCT06602453

Public ClinicalTrials.gov record NCT06602453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 10:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events

Study identification

NCT ID
NCT06602453
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
67 participants

Conditions and interventions

Interventions

  • GDC-8264 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2025
Primary completion
Mar 2, 2026
Completion
Mar 2, 2026
Last update posted
Mar 15, 2026

2025 – 2026

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
University of Stanford Medical Center Stanford California 94305-2200
James A Haley Veteran Affairs Medical Center - NAVREF - PPDS Tampa Florida 33612-4745
John Hopkins Hospital Lutherville Maryland 21093
Baystate Cardiac Surgery Springfield Massachusetts 01107
Mayo Clinic - PPDS Rochester Minnesota 55905-0001
CHI Health Nebraska Heart Lincoln Nebraska 68526-9437
Duke University Medical Center Durham North Carolina 27705
University of Texas Southwestern Medical Center Dallas Texas 75390-7202
Richmond VA Medical Center NAVREF PPDS Richmond Virginia 99999

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06602453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06602453 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →